KMKwartarini Murdiastuti

Kwartarini Murdiastuti

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kwartarini Murdiastuti has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

  • Dahlia Herawati

    Departement of Periodontia, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta, Indonesia

    3 shared publications
  • Dharmmesti Anindita Wijayanti

    Periodontics Specialisation Study Program, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta, Indonesia

    3 shared publications
  • Vincensia Maria Karina

    Doctoral Study Program, Faculty of Dentistry, Universitas Gadjah Mada Yogyakarta, Indonesia

    3 shared publications
  • Fitri Yuniawati

    Clinical Dentistry Program, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta, Indonesia

    2 shared publications
  • Mardha Ade Pritia

    Periodontics Specialisation Study Program, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta-55281, Indonesia

    2 shared publications
  • Abyan Teguh Saputro

    Periodontics Specialisation Study Program, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta, Indonesia

    1 shared publication

Latest Publications

  • Open Access

    Evaluation of Chitosan–Polyvinyl Alcohol Nanofiber Loaded with Injectable Platelet-Rich Fibrin as Promising Candidate for Periodontal Membrane

    by Vincensia Maria Karina, Nur Rahman Ahmad Seno Aji, Osa Amila Hafiyyah, Mentari Salma Nurbaiti, Deniar Faizya Widhawati, Tasya Amira, Ronny Martien, Ahmad Kusumaatmaja, Kwartarini Murdiastuti

    This study aimed to evaluate the feasibility of incorporating injectable platelet-rich fibrin (i-PRF) into electrospun chitosan–polyvinyl alcohol (PVA) nanofibers by assessing (1) swelling behavior after immersion in i-PRF, (2) potential interactions between components based on Fourier transform infrared spectroscopy (FTIR) profiles, and (3) initial in vitro cytocompatibility using human primary fibroblasts. Chitosan–PVA nanofibers were fabricated by electrospinning and trimmed into 5-mm discs. Specimens were immersed in 0.5 mL of i-PRF for six time points (5, 10, 15, 20, 25, and 30 minutes), and swelling capacity was evaluated to determine the immersion time associated with the highest absorption. FTIR was performed to compare functional group profiles before and after i-PRF immersion. For cytocompatibility testing, 5-mm diameter nanofiber discs were soaked in 0.5-mL i-PRF for 10 minutes and placed into wells seeded with human primary fibroblasts (5 × 103 cells/well). After 24, 48, and 72-hour incubation at 37°C in a CO2 incubator, methylthiazol tetrazolium (MTT) reagent was added and incubated for an additional 4 hours. Absorbance was measured using a multimode microplate reader, and cell viability was calculated as the percentage relative to the control group. The highest swelling was observed after 10 minutes of immersion (p < 0.05). FTIR spectra showed no additional peaks indicative of new chemical functional groups after immersion, suggesting that i-PRF incorporation occurred predominantly through physical interaction rather than formation of new covalent bonds. In the MTT assay, fibroblast viability in the i-PRF-immersed nanofiber group was comparable to the control (p < 0.05), indicating no detectable cytotoxic effect under the tested conditions. Chitosan–PVA nanofibers demonstrated an ability to absorb i-PRF, exhibiting comparable FTIR functional groups following immersion. This finding indicates that the predominant interaction mechanism is of a physical nature. A 72-hour MTT assay indicated that there was acceptable initial cytocompatibility with human primary fibroblasts. The study concluded that the chitosan–PVA/i-PRF construct appears to be a promising preliminary scaffold, but further work is required on morphology, mechanics, degradation, release kinetics, wider cell responses, and in vivo performance before claims can be made about periodontal regeneration or clinical efficacy. For this study, a written informed consent was obtained from each volunteer prior to every procedure, including tooth extraction and blood withdrawal. The informed consent form was reviewed and approved by the research ethics committee. Article published online: 25 March 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Medical and Scientific Publishers Pvt. Ltd. A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

  • Open Access

    GINGIVAL RECESSION TREATMENT BY TUNNELING, PLATELET-RICH FIBRIN MEMBRANE, DOUBLE CROSS SUTURE WITH BELT-SUSPENDERS TECHNIQUE

    by Mardha Ade Pritia, Kwartarini Murdiastuti

    Objective: Gingival recession by treating tunneling technique can minimize flap opening so that obtain more adequate blood supply. The addition of a platelet-rich fibrin (PRF) membrane enhances the healing process due to the presence of growth factors. Apart from that, the double cross suture combined with the belt and suspenders technique can also help the success of the treatment. Methods: A 30 y old female came in complaining her teeth had felt sore for the last 1 y. Complaints increased when brushing teeth and drinking cold drinks, especially on the upper right teeth. The etiology was due to an error in brushing teeth, resulting in gingival recession on teeth 13 of 1 mm and 15 of 2 mm (class 1 Miller). Alveolar bone did not decrease on radiographs. The initial treatment was done by scaling and polishing, followed by the application of desensitizing agents to reduce pain, the patient was instructed to replace her toothbrush type and trained with the modified Stillman method. The surgery used tunneling with PRF membrane, sutured by a double cross combined with the belts-suspenders technique. The controls were done after days 7, 14, 30, 90 and 120. Results: The results showed that gingival recession on teeth 13 and 15 was corrected 100% from 1 mm and 2 mm to 0 mm. After day 120, there were no complaints of pain or aches, and the patient was satisfied. Conclusion: The combination tunneling, PRF membrane, sutured by double cross combined with belts and suspenders technique could be an alternative treatment in cases of Miller class 1 gingival recession stable up to 120 d.

  • Open Access

    Effect of Centrifugation Methods on the Regenerative Potential of Concentrated Platelet-Rich Fibrin: An In Vitro Study

    by Kwartarini Murdiastuti, Abyan Teguh Saputro, Dharmmesti Anindita Wijayanti

    A new type of platelet concentrate used in regenerative periodontal therapy, called concentrated platelet-rich fibrin (C-PRF), contains more growth factors than previous generations of platelet concentrate. Compared to fixed-angle centrifugation, a recently discovered technique called horizontal centrifugation can produce C-PRF with a more evenly distributed quantity of platelets and improved biological properties. This study aims to determine the effect of horizontal and fixed-angle centrifugation methods on the release of transforming growth factor β1 (TGF-β1) and platelet-derived growth factor AB (PDGF-AB), as well as on the migration and proliferation of osteoblast cells. This study used two test groups: a horizontal group and a fixed-angle group. The release of growth factors TGF-β1 and PDGF-AB was measured at five time points: the first, third, seventh, 10th, and 14th days of incubation, using the enzyme-linked immunosorbent assay. To determine the effect of C-PRF type on osteoblast cell migration, a scratch wound healing assay was conducted 24 hours after incubation. Osteoblast cell proliferation was counted using a 450-nm microplate reader to determine the number of cells in the well plate on the first, third, and fifth days, with the Cell Counting Kit-8. The data were examined using two-way ANOVA (analysis of variance) and post hoc LSD (least significant difference). The findings indicated a statistically significant increase in the release of TGF-β1 and PDGF-AB in the horizontal group compared to the fixed-angle group over a 14-day period. The horizontal group's TGF-β1 release increased by a factor of 1.5 compared to the fixed-angle group, peaking on day 7. Following a 24-hour incubation period and microscopic examination, the horizontal group exhibited greater osteoblast migratory activity than the control group and the fixed-angle centrifugation group. Horizontal centrifugation C-PRF had a significantly greater effect on osteoblast proliferation than fixed-angle centrifugation. The horizontal group's proliferation rate surpassed that of the fixed-angle group by up to 1.5 times on the third day of observation. Compared to fixed-angle centrifugation, the horizontal method of preparing C-PRF has a greater effect on the release of growth factors and the behavior of osteoblasts. For this study, informed written consent was provided to conduct the outlined experiments prior to the blood collection from volunteers. Article published online: 07 November 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Medical and Scientific Publishers Pvt. Ltd. A-12, 2nd Floor, Sector 2, Noida-201301 UP, India


  • Open Access

    Hydrogel and Injectable Platelet-Rich Fibrin: A Synergistic Approach to Osteogenesis

    by Kent Sidharta, Suryono Suryono, Mardha Ade Pritia, Kwartarini Murdiastuti

    Injectable platelet-rich fibrin (i-PRF) features a higher concentration of growth factor and lower viscosity compared with PRF, making it advantageous for periodontal regenerative therapy. However, its low mechanical property and high degradation rate cause its limited usage in bone augmentation. Hydrogel interacts with i-PRF, which is expected to replace bone graft considering its disadvantages. Through the synergistic effects of the materials, a sustained release of growth factor is achieved, promoting bone formation and maturation. Osteogenic markers, including alkaline phosphatase (ALP) activity and calcium deposition, were measured at intervals of 1, 7, 14, and 21 days using osteoblast-like cells. In vivo study using the extraction socket of Wistar rat applied with the same material was also done and measured at 21 and 42 days. The study included three groups: hydrogel i-PRF, bone graft (FDBA) i-PRF, and a control (blank hydrogel) group. Measurements utilized ALP staining and Alizarin red S assays for the in vitro study and bone dimension for the in vivo study. Hydrogel i-PRF significantly enhanced ALP activity on days 7 and 14 compared with the bone graft i-PRF and control groups (p ≤ 0.05). Similarly, calcium deposition was notably higher in the hydrogel i-PRF group on days 14 and 21. Hydrogel i-PRF also preserves the bone dimension of the rat's extraction socket compared with bone graft i-PRF. These findings highlight the superior bone regeneration capacity of the hydrogel when combined with i-PRF, attributed to enhanced osteoblast proliferation, differentiation, and mineralization mediated by PDGF and BMP bound to collagen fibrils. Hydrogel with i-PRF exhibits improved osteogenic capability compared with bone grafts, showing promise as an alternative material for periodontal regenerative applications.


  • Open Access

    Combination of Collagen-Chitosan Hydrogel and Injectable Platelet-Rich Fibrin as a Biomaterial for Bone Regeneration: Characterization and Growth Factor Release Pattern

    by Dharmmesti Anindita Wijayanti, Gusti Ngurah Komang Agus Wirajaya, Nuansa Hanum Pratiwi, Vincensia Maria Karina, Kwartarini Murdiastuti

    The release of growth factors in injectable platelet-rich fibrin (I-PRF) exhibits a peak within 24 hours and subsequent decline by day 10, underscoring immediate application, limiting its effectiveness in alveolar bone repair. In order to enhance its regenerative potential, I-PRF can be combined with biomaterial scaffolds such as collagen-chitosan hydrogels, which mimic the extracellular matrix and support tissue regeneration. This combination has been shown to enhance cellular signaling and tissue repair. This study aimed to analyze the characterization of collagen-chitosan hydrogels with I-PRF and determine the growth factor release pattern that occurs after mixing. Collagen-chitosan hydrogels were prepared and combined with I-PRF at a 1:1 ratio. The structural characterization of these hydrogels, both with and without I-PRF, was performed using Fourier transform infrared spectroscopy (FTIR), enabling the comparison of absorption bands. Furthermore, the release profiles of transforming growth factor-beta 1 (TGF-β1) and platelet-derived growth factor AB (PDGF-AB) were assessed in two experimental groups: The first group consisted of I-PRF alone, while the second group comprised of I-PRF combined with collagen-chitosan hydrogels. Growth factor release was evaluated at multiple time points (days 1, 3, 5, 7, 9, 11, 13, 15, and 17) using enzyme-linked immunosorbent assay. The resulting absorbance values were converted into concentration measurements (pg/mL) using a standard calibration curve. Statistical analysis was conducted using two-way analysis of variance followed by a post hoc least significant difference test. FTIR analysis demonstrated that the functional groups present in the collagen-chitosan hydrogel remained unchanged following the incorporation of I-PRF, confirming the formation of physical rather than chemical bonds. Subsequent analysis revealed statistically significant differences in the release patterns of TGF-β1 and PDGF-AB between the two groups (p < 0.05). The combination of collagen-chitosan hydrogel and I-PRF exhibited a more stable and sustained release profile from day 1 to day 17. The combination of I-PRF with collagen-chitosan hydrogels does not alter the fundamental chemical structure of the scaffold. However, this combination does influence the controlled release of growth factors. This finding indicates that the synergistic interaction between collagen and chitosan enhances the hydrogel's properties, suggesting its potential as a promising biomaterial for use as a scaffold in bone regeneration.


  • Open Access

    CHITOSAN COLLAGEN HYDROGEL: A POTENTIAL SCAFFOLD BIOMATERIAL FOR PERIODONTAL REGENERATIVE TREATMENT

    by Dharmmesti Anindita Wijayanti, Dahlia Herawati, Vincensia Maria Karina, Kwartarini Murdiastuti

    Introduction: Hydrogels are considered a promising scaffold biomaterial for regenerative periodontal treatment. The development of collagen and chitosan based hydrogels can improve the final characteristics of the hydrogel. Review: Collagen and chitosan are the two main materials used to design scaffolds for tissue engineering. Collagen is a material that is often used to develop hydrogels because it has the advantage of high biocompatibility. In the biomedical field, collagen is often used as a drug delivery system. Collagen has weak mechanical strength so other biomaterials are needed for its use. Chitosan material has high biocompatibility and a slow degradation rate. So the combination of these two materials is a strategic choice for making promising biomaterial scaffolds in periodontal regenerative treatment. Conclusion: Chitosan collagen hydrogel is a potential scaffold biomaterial for periodontal regenerative treatment.


  • Open Access

    Freeze-Dried human platelet-rich plasma effect on osteoblast number and collagen density in periodontitis treatment

    by Nandini A. Sumitro, Hapsari K. Prathivi, Kwartarini Murdiastuti

    Objective: This study aimed to determine the effect of FD-hPRP on the number of osteoblast and collagen density in periodontitis treatment by a histomorphometric study on oryctolagus cuniculus rabbits' alveolar bone and periodontal ligament. Material and Methods: Sixteen male rabbits were randomly divided into four groups: Normal; Periodontitis; FD-hPRP; DFDBA. After periodontal surgery by open flap debridement, FD-hPRP was applied in group 3, and DFDBA was applied in group 4. Then all rabbits were decapitated eight weeks after surgery. Histomorphometric analysis calculates the number of osteoblasts and collagen density using image J software. Data were analyzed using one-way ANOVA followed by Post Hoc Least Significant Difference (LSD) test. Results: The results showed a significant difference (p>0.05) between the periodontitis and FD-hPRP and also DFDBA group. Conclusion: The application of FD-hPRP effect increases the number of osteoblast and collagen density in periodontitis treatment histomorphometrically in rabbit’s alveolar bone and periodontal ligament.

  • Open Access

    Osteocalcin levels evaluation of freeze-dried homologus platelet-rich plasma in periodontal treatment

    by Niken Olivia, Kwartarini Murdiastuti

    Objective: The aim of this study was to evaluate enhanced osteocalcin levels by using freeze-dried homologous platelet-rich plasma (FD HPRP) in periodontal treatment to support the osteogenesis process. Material and Methods: FD HPRP was made by HPRP from the blood bank, then freeze-drying and for sterilization, the γ-radiation process was carried out with doses of 20 and 25 kGy. The osteoblast (Cell line MG63) was cultured to confluent and then treated with FD HPRP 20 kGy, FD HPRP 25 kGy. Osteocalcin levels were tested using enzyme-linked immunosorbent assay (ELISA) on the 7th and 14th days. The data were analyzed using a t test Results: There was a significant difference in the osteocalcin levels between FD HPRP 20 and FD HPRP 25 (p<0.05). Osteocalcin levels increased on day 14 in each group and the highest one on the 7th and 14th days was FD HPRP 25. Conclusion: The present results showed that FD HPRP with simple preparation could support the osteogenesis process

  • Open Access

    Effect of advanced-platelet rich-fibrin combined with rosuvastatin application after open flap debridement of infrabony pocket

    by Tissa Rahadianti, Dahlia Herawati, Kwartarini Murdiastuti

    Open flap debridement (OFD) is an invasive therapy for chronic periodontitis with pocket 5 mm or more. However, it is difficult to achieve regeneration and new attachment with this therapy. Periodontitis starts to add growth factors and local drugs delivery as host modulation therapy. Advanced-PRF (A-PRF) contains more growth factor than PRF which plays a role in promoting fibroblast proliferation, reepithelization, extracellular matrix production, and endothelial cell migration. 1.2% rosuvastatin gel (RSV) is a local delivery drug with a pleiotropic effect that can modify host response to promoting BMSCs, BMP-2, OPG, ALP, RANKL, and osteoblasts. This study aimed to examine the effect of the application of A-PRF+RSV in OFD therapy of which the parameters were probing depth (PD), relative attachment loss (RAL), and alveolar bone height. The study samples consisted of 24 periodontal pockets which were divided into 2 groups of 12 pockets each, namely A-PRF+RSV for group 1 and PRF+RSV for group 2. Clinical evaluations were carried out on baseline, day-30, and day-90 for PD and RAL, and on baseline and day -90 for alveolar bone height. Data of PD and RAL reduction were analyzed with non-parametric test Mann-Withney, while data of reduction of alveolar bone height were analyzed with parametric Independent-T test. Group 1 obtained a statistically more significant result in reducing PD, RAL, and alveolar bone height compared to group 2 (p<0.05) To conclude, the application of A-PRF and 1.2% rosuvastatin gel in OFD procedure promotes a higher PD and RAL reduction and alveolar bone height increase than the application of PRF coupled with 1.2% rosuvastatin gel.